Senate approves bills to limit costs for inhalers and diabetes supplies
PROVIDENCE – The state
The bills, which now go to the
One bill (2026-S 2877) caps copays for a 30-day supply of insulin administration and glucose monitoring supplies at
Like the 2021 state law – also sponsored by
The second bill (2026-S 2876) would cap insured patients' costs for prescription asthma inhalers for an FDA-approved respiratory condition at
The average cost of an inhaler has risen sharply in the last 15 years, as new designs for inhalers have allowed drugmakers to increase the price of the inhaler even as the drug inside has not changed, states the release.
Both bills would take effect


UBS Group AG Grows Position in Rithm Capital Corp. $RITM
NC House lawmakers push for better breast cancer detection
Advisor News
- IRI pitches retirement agenda to Jeffries as democrats shape affordability platform
- Help child-free clients plan for their later years
- When new investment trends emerge, Gen Z is most likely generation to be first in
- Could ‘plain English’ become an advisor’s secret weapon?
- IRI urges Senate action on 403(b) parity legislation
More Advisor NewsAnnuity News
- Guidance, bulletin or reg? NAIC debates form of annuity illustration update
- Nationwide adds mutual fund-linked strategy to New Heights Select FIA
- NUNN INTRODUCES BILL TO CUT RED TAPE, GIVE IOWANS CLEARER INSURANCE INFORMATION
- NAIC working group pressed to accelerate annuity illustration overhaul
- State Auditor James Brown Kicks Off Life Insurance Awareness Month With Policy Locator Tool
More Annuity NewsHealth/Employee Benefits News
Life Insurance News